Abstract
Hepatocellular carcinoma (HCC) is a common malignant tumor in China. In the present study, we aimed to construct and verify a prediction model of recurrence in HCC patients using databases (TCGA, AMC and Inserm) and machine learning methods and obtain the gene signature that could predict early relapse of HCC. Statistical methods, such as feature selection, survival analysis and Chi-Square test in R software, were used to analyze and select mutant genes related to disease free survival (DFS), race and vascular invasion. In addition, whole-exome sequencing was performed on 10 HCC patients recruited from our center, and the sequencing results were compared with the databases. Using the databases and machine learning methods, the prediction model of recurrence was constructed and optimized, and the selected mutant genes were verified in the test group. The accuracy of prediction was 74.19%. Moreover, these 10 patients from our center were used to verify these mutant genes and the prediction model, and a success rate of 80% was achieved. Collectively, we discovered recurrence-related genes and established recurrence prediction model of recurrence for HCC patients, which could provide significant guidance for clinical prediction of ...Continue Reading
References
Nov 5, 2014·Nature Genetics·Yasushi TotokiTatsuhiro Shibata
Mar 31, 2015·Nature Genetics·Kornelius SchulzeJessica Zucman-Rossi
Apr 12, 2016·Nature Genetics·Akihiro FujimotoHidewaki Nakagawa
Sep 28, 2016·Cell Research·Fei LiHongbin Ji
Dec 16, 2016·Gut·Daniel W H HoIrene O L Ng
Feb 28, 2017·Journal of Hepatology·Atsushi ObaShinji Tanaka
Mar 24, 2017·Carcinogenesis·Yao LiuJianming Li
Apr 20, 2017·Medicine·Chunxiao ZhuTao Huang
May 13, 2017·Cancer Science·Qingzhu GaoNi Tang
Jun 8, 2017·Journal of Gastroenterology and Hepatology·Xiaofeng ZhangWan Yee Lau
Jun 18, 2017·Cell·UNKNOWN Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, UNKNOWN Cancer Genome Atlas Research Network
Jul 13, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Cheng-Kun YangTao Peng
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 21, 2018·Theranostics·Xiangchun LiJun Yu
Mar 25, 2018·Cancer Science·Tatsuhiro ShibataYasushi Totoki
Jun 14, 2018·Scientific Reports·Michał GrątKrzysztof Zieniewicz
Aug 3, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chiao-Ling LiShiou-Hwei Yeh
Aug 18, 2018·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Han WangWen-Ming Cong
Aug 26, 2018·Clinics and Research in Hepatology and Gastroenterology·Ye ZhouFang Zheng
Nov 16, 2018·Experimental & Molecular Medicine·Gena LeeSun Young Yim
Jan 29, 2019·The Journal of Pathology·Nancy M JosephGregor Krings
May 11, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Li YinQianfeng Xia
May 31, 2019·Scientific Reports·Masaya SatoYutaka Yatomi
Sep 29, 2019·Gastroenterology·Xiaofan DingNathalie Wong
Oct 5, 2019·Cell·Qiang GaoJia Fan
Citations
Jan 6, 2021·Cancers·Alana SorginiAnthony C Nichols
Feb 11, 2021·Biomedicines·Nurbubu T MoldogazievaAlexander A Terentiev
Jun 3, 2021·Cancers·Pattapon KunadirekPisit Tangkijvanich
Jul 17, 2021·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Clara BalsanoUNKNOWN Special Interest Group (SIG) Artificial Intelligence and Liver Diseases; Italian Association for the Study of the Liver (AIS